← Dashboard
Jun 02, 2026 09:47 PM ET
Catalyst
Corporate
$CRSP
- CRISPR THERAPEUTICS FILES FORM 4 WITH SEC
CRSP
$59.42
+0.32%
What changed
- CRISPR THERAPEUTICS FILES FORM 4 WITH SEC
Why it matters
High-priority alert based on source significance and keyword relevance.
Sources
sec
Related signals
FITCH AFFIRMS CHINA CREDIT RATING AT 'A' →
FITCH ISSUES NEW STATEMENT AND OUTLOOK ON U.S . CREDIT RATING DEBT WARNING IN FIRST PARAGRAPH . →
SCOTT BESSENT SURPRISE BOND BUYBACK SPARKS A SILVER RALLY . IS IT TOO LATE TO BUY IN ? →